Instead, additional factors, such as mutations of TP53 and IDH1/2, were found to correlate with progression to MF and/or AML [26] and are primarily found in overt PMF and MPN-BP, but rarely in ET or PV [27,28,29]. Here, IDH1 is linked to myeloproliferative neoplasm.